📰 Andreaf Wainer News
Page 25 - Andreaf Wainer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Andreaf Wainer. Real-time updates on events, politics, business and more.
February 19, 2024
Rathbones Group PLC boosted its position in Abbott Laboratories (NYSE:ABT – Free Report) by 9.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,137,574 shares of the healthcare product maker’s stock after buying an additional 183,803 shares during the […]
February 18, 2024
Columbia Asset Management lowered its position in Abbott Laboratories (NYSE:ABT – Free Report) by 18.7% during the third quarter, HoldingsChannel reports. The institutional investor owned 5,641 shares of the healthcare product maker’s stock after selling 1,300 shares during the period. Columbia Asset Management’s holdings in Abbott Laboratories were worth $546,000 as of its most recent […]
February 18, 2024
Columbia Asset Management trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 18.7% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 5,641 shares of the healthcare product maker’s stock after selling 1,300 shares during the quarter. Columbia Asset […]
February 18, 2024
Columbia Asset Management trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 18.7% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 5,641 shares of the healthcare product maker’s stock after selling 1,300 shares during the quarter. Columbia Asset […]
February 17, 2024
Balentine LLC lessened its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 23,196 shares of the healthcare product maker’s stock after selling 205 shares during the quarter. […]
February 17, 2024
WINTON GROUP Ltd cut its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 18.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 48,740 shares of the healthcare product maker’s stock after selling 10,747 shares during the quarter. WINTON GROUP Ltd’s […]
February 17, 2024
TRUE Private Wealth Advisors reduced its position in Abbott Laboratories (NYSE:ABT – Free Report) by 2.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,180 shares of the healthcare product maker’s stock after selling 117 shares during the quarter. TRUE […]
February 16, 2024
Transatlantique Private Wealth LLC increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 22.0% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,610 shares of the healthcare product maker’s stock after purchasing an additional 650 shares during the quarter. Transatlantique […]
February 16, 2024
Wealthsource Partners LLC trimmed its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.2% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 9,468 shares of the healthcare product maker’s stock after selling 119 shares during the period. Wealthsource Partners LLC’s holdings in Abbott Laboratories were worth […]
February 16, 2024
Wealthsource Partners LLC cut its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.2% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 9,468 shares of the healthcare product maker’s stock after selling 119 shares during the quarter. Wealthsource Partners LLC’s […]